SCHEMBL29405925

SCHEMBL29405925

Cn1nc(C(F)(F)F)cc1NC(=O)c1ccc2cc(-c3ccc(F)cc3F)cnc2c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ STIM1 Q13586 1/20 0.39
▸ ORAI1 Q96D31 1/20 0.39
▸ KLKB1 P03952 1/20 0.39
▸ NTRK1 P04629 3/20 0.39
▸ BRAF P15056 3/20 0.38
▸ HTR2C P28335 1/20 0.38
▸ MCHR1 Q99705 1/20 0.38
▸ FLT3 P36888 1/20 0.38
▸ ABL1 P00519 1/20 0.38
▸ HPGDS O60760 1/20 0.38
▸ DGAT2 Q96PD7 1/20 0.37
▸ TP53 P04637 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ AKR1C3 P42330 2/20 0.37
▸ AKR1C2 P52895 2/20 0.37
▸ KCNT1 Q5JUK3 1/20 0.37
▸ LMNA P02545 1/20 0.37
▸ WNT1 P04628 1/20 0.37
▸ GSK3B P49841 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22659804 1.00 STIM1 (0.39) STIM1ORAI1KLKB1NTRK1BRAF
SCHEMBL22659007 0.93 BRAF (0.45) KLKB1NTRK1BRAFHTR2CMCHR1
SCHEMBL24571432 0.91 NTRK1 (0.42) STIM1ORAI1NTRK1BRAFFLT3
SCHEMBL22659083 0.90 HTR2C (0.44) STIM1ORAI1NTRK1BRAFHTR2C
SCHEMBL22659187 0.89 KCNT1 (0.40) STIM1ORAI1NTRK1BRAFFLT3
SCHEMBL22659218 0.88 BRAF (0.39) STIM1ORAI1NTRK1BRAFFLT3
SCHEMBL22658921 0.88 STIM1 (0.41) STIM1ORAI1NTRK1BRAFHTR2C
SCHEMBL22659819 0.87 MCHR1 (0.41) STIM1ORAI1NTRK1BRAFHTR2C
SCHEMBL22659073 0.86 BRAF (0.40) STIM1ORAI1NTRK1BRAFFLT3
SCHEMBL24571228 0.86 STIM1 (0.42) STIM1ORAI1NTRK1BRAFFLT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3966208-A2 COMPOUNDS AND METHODS FOR TREATING CANCER Antidote IP Holdings, LLC (US) 2022-03-16 — — EP disclosed
Send feedback